Inventiva (IVA) Shares Outstanding (Diluted Average) (2018 - 2025)

Inventiva (IVA) recorded quarterly Shares Outstanding (Diluted Average) of $217.4 million in Q4 2025, up 11857704.3% quarter-over-quarter from $1833.8 in Q2 2025, and up 240.4% on a YoY basis from $63.9 million in Q4 2024.

Inventiva (IVA) Shares Outstanding (Diluted Average) (2018 - 2025) Analysis & Trends

Inventiva's Shares Outstanding (Diluted Average) history runs 8 years deep, the most recent figure standing at $217.4 million for Q4 2025.

  • In Q4 2025, Shares Outstanding (Diluted Average) rose 240.4% year-over-year to $217.4 million; the TTM figure through Dec 2025 stood at $217.4 million (up 240.4% YoY), while the FY2025 annual figure was $217.4 million, up 240.4% from the prior year.
  • Shares Outstanding (Diluted Average) was $217.4 million for Q4 2025 at Inventiva, up from $1833.8 in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $217.4 million in Q4 2025 to a low of $768.28 in Q2 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $50.6 million across 5 years, with a median of $45.8 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) slumped 100.0% in 2022, then jumped 5959127.8% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $44.8 million in 2021, then fell by 5.62% to $42.3 million in 2022, then advanced by 15.39% to $48.8 million in 2023, then soared by 30.91% to $63.9 million in 2024, then jumped by 240.4% to $217.4 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $217.4 million (Q4 2025), $1833.8 (Q2 2025), and $63.9 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 4,489.46 Bn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 810.00
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 118.76 Bn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 256.30 Mn
9 Abivax 95.45 Bn 95.45 Bn - 92.44 Mn
10 Inventiva 8.93 Mn -259.80 Mn - 217.45 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 217.45 Mn
Jun 30, 2025 1,833.77
Dec 31, 2024 63.88 Mn
Jun 30, 2024 1,012.27
Dec 31, 2023 48.80 Mn
Jun 30, 2023 45.78 Mn
Dec 31, 2022 42.29 Mn
Jun 30, 2022 768.28
Dec 31, 2021 44.81 Mn
Jun 30, 2021 46.58 Mn
Mar 31, 2021 46.56 Mn
Dec 31, 2020 40.39 Mn
Jun 30, 2020 42.60 Mn
Mar 31, 2020 32.05 Mn
Dec 31, 2019 26.03 Mn
Dec 31, 2018 23.45 Mn